ACA
ZBH icon

Aptus Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Aptus Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$553K Sell
6,117
-216
-3% -$19.8K ﹤0.01% 696
2025
Q4 		$569K Buy
6,333
+539
+9% +$51.1K ﹤0.01% 699
2025
Q3 		$571K Buy
+5,794
New +$574K ﹤0.01% 672

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aptus Capital Advisors's ZBH Position: Q1 2026 in Review

Aptus Capital Advisors reduced its Zimmer Biomet (ZBH) stake by 3.4% in Q1 2026, selling an estimated $19.8K and leaving 6,117 shares worth $553K. The position accounts for ﹤0.01% of the portfolio, ranked #696.

Aptus Capital Advisors first reported a position in ZBH in Q3 2025 and has held it in 3 quarters since. The position peaked at $571K in Q3 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Aptus Capital Advisors held 6,117 shares of Zimmer Biomet worth $553K as of Q1 2026.
  • Aptus Capital Advisors sold 216 Zimmer Biomet shares in Q1 2026, an estimated $19.8K.
  • Zimmer Biomet made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q1 2026, its #696 holding.
  • Aptus Capital Advisors first reported a position in Zimmer Biomet in Q3 2025 and has held it in 3 quarters since.
  • Aptus Capital Advisors's Zimmer Biomet position peaked at $571K in Q3 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Aptus Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.